News & Updates

A US study reports about one in four top-performing hospitals being reclassified to a lower performance group when Medicare Advantage (MA) beneficiaries are included in the assessment of hospital readmission and mortality.

The combination of bevacizumab and irinotecan (BEV+IRI) as second-line treatment of glioblastoma (GBM) results in better median progression-free (PFS) and overall survival (OS) when compared with historical controls, and its toxicity profile is comparable to published data, reports a study.

One cardiac arrest occurs for every 9,000 delivery hospitalizations, among which about seven in 10 women survive to be discharged from the hospital, according to a study. In addition, survival is lowest during hospitalizations with co-occurring disseminated intravascular coagulation (DIC).

Among individuals with psoriasis, oral vitamin D supplementation does not appear to have any favourable effect on disease severity for those with low 25-hydroxyvitamin D (25[OH]D) levels, as reported in a study.

Metabolic and bariatric surgery (MBS) significantly reduced BMI in severely obese adolescents compared with intensive nonsurgical treatment in the AMOS2* study.

The use of antifibrotic therapy in patients with idiopathic pulmonary fibrosis (IPF) has the potential to improve survival outcome, as reported in a study.